Bolstered by a $1.6 million grant, Dr. Timothy Bolger, at the University of Arizona Cancer Center, is studying how cells respond to stress and the role this process has in cancer growth and aging.

Inappropriate medications – such as oleandrin, a derivative of oleander known to be toxic – used to prevent or treat COVID-19 could cause significant harm and no benefit, University of Arizona Health Sciences-based center and Banner Health center warn.

Understanding how cells respond to stress may provide new building blocks for designing future cancer and aging treatments. Timothy Bolger, a researcher at the University of Arizona Cancer Center, received a $1.6 million grant from the National Institutes of Health to investigate how cells respond to stress and the role this process may have in cancer growth and aging.

A University of Arizona Health Sciences cohort study of more than 50,000 menopausal women showed significant decrease in Alzheimer’s disease diagnosis.

"A thermometer that is cost-effective, reliable and easily cleaned between uses makes a thermometer good for families," said Dr. Farshad Fani Marvasti, director of the public health curriculum for the University of Arizona College of Medicine – Phoenix.

Arizona's COVID-19 reproduction number – a measure of whether a disease is spreading or contracting, also called R0 – is the lowest in the nation, by one count, just eight weeks after the state was in headlines as a coronavirus hot spot. But University of Arizona epidemiologist Purnima Madhivanan from the Mel and Enid Zuckerman College of Public Health, urged caution at the R0 news.

The University of Arizona College of Nursing is among the beneficiaries of a $1.5 million gift from UA alumni Andrew and Kirsten Braccia. The vast majority of the gift, $1 million, will support next-generation education for nursing students, enhancing simulation capabilities, providing students online access to virtual patient experiences, and supporting and augmenting technology needed for distance learning due to COVID-19.

The U.S. has granted emergency authorization for convalescent plasma, but experts say the science around the treatment isn't settled. University of Arizona College of Medicine – Tucson researcher and ICU medical director Christian Bime isn’t concerned about political pressure – out of confidence in the scientists embedded in the process. "I trust scientists to do the right thing," Bime said. "The stakes are too high and the consequences too dire for scientists to not follow best practice."

The University of Arizona had its first day of in-person classes Monday as people on and off-campus worry that a rise in cases will inevitably follow students' return to Tucson. "We feel that we've done a very good job about creating an environment that's receptive to our students, staff and faculty returning in the increments we have explained. But they've got to adhere to those public health practices,” said Dr. Richard Carmona, head of the Campus Reentry Task Force and distinguished professor of public health.

Following a dramatic surge of coronavirus cases between June and July, numbers across the United States have largely decreased, which experts attribute to local mask mandates and other precautionary measures, like restaurant and bar closures. Joe Gerald, an associate professor of public health policy at the University of Arizona, attributed the decrease to mask orders in the state's biggest cities, news media coverage of the heightened risk and also the closure of bars, gyms and theaters after they started reopening in May.